Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Armata Pharmaceuticals, Inc. (ARMP) had Debt to Equity Ratio of -1.23 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$2.51M |
|
$74.14M |
|
-- |
|
$2.51M |
|
$12.82M |
|
$-10.31M |
|
$84.45M |
|
$74.14M |
|
$74.14M |
|
$74.14M |
|
$74.14M |
|
$74.14M |
|
$74.14M |
|
$-10.31M |
|
$-9.72M |
|
36.75M |
|
62.04M |
|
$2.02 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$27.16M |
|
$11.23M |
|
$62.79M |
|
$89.95M |
|
$250.20M |
|
$42.02M |
|
$70.92M |
|
$321.12M |
|
$-231.17M |
|
$-234.66M |
|
$-231.17M |
|
37.15M |
|
| Cash Flow Statement Financials | |
$-14.45M |
|
$-0.08M |
|
$28.52M |
|
$14.08M |
|
$28.07M |
|
$13.99M |
|
$4.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.22 |
|
|
Debt to Equity Ratio |
-1.23 |
100.00% |
|
-410.84% |
|
-410.84% |
|
-- |
|
2953.82% |
|
2953.82% |
|
$-14.53M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.99 |
|
90.79 |
|
-32.07% |
|
-31.59% |
|
82.42% |
|
-39.20% |
|
$-6.22 |
|
$-0.23 |
|
$-0.23 |
|